Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science | Journal of Medicinal Chemistry
IJMS | Free Full-Text | High Throughput Proteomic Exploration of Hypothermic Preservation Reveals Active Processes within the Cell Associated with Cold Ischemia Kinetic
Cerep and Servier Enter Collaboration Agreements | Technology Networks
Thierry Jean - President - Levitha SPRL | LinkedIn
Thierry Jean email address & phone number | MImAbs President and CEO contact information - RocketReach
Thierry Jean - President - Levitha SPRL | LinkedIn
Thierry Jean - President - Levitha SPRL | LinkedIn
Eurobiomed : Portrait d'entreprise
Jean thierry Banque de photographies et d'images à haute résolution - Alamy
Thierry Jean email address & phone number | MImAbs President and CEO contact information - RocketReach
Thierry Jean - President - Levitha SPRL | LinkedIn
PerkinElmer and Cerep partner on drug discovery
Comex: Antibodies for medicine
Thierry Jean - President - Levitha SPRL | LinkedIn
Thierry Jean - President - Levitha SPRL | LinkedIn
PerkinElmer and Cerep partner on drug discovery
Cerep change de mains
Cerep prépare son introduction sur l'Easdaq | Les Echos
Eurofins-Cerep annonce la nomination de son nouveau Président directeur général ▫ Contact
3rd quarter 2008 consolidated sales revenues
PerkinElmer and Cerep announce expansion of new kinase assay offerings to accelerate drug candidate screening and validation
Cerep grants a BioPrint® evaluation licence to Roche
Centre Presse : Laboratoire Cerep : un rebond après le plan social ?
dpa) - Thierry Jean, the founder and CEO of the French biotechnology group Cerep S.A., pictured in Frankfurt, 14 May 2003 Stock Photo - Alamy
Thierry Jean quitte la tête de Cerep
PerkinElmer Partners with Cerep for Custom Drug Discovery Solutions
Thierry Jean quitte la tête de Cerep
Doc de réf - RFA 2010
